I'm referring to Aderans and more specifically Histogen. I beleive the lastest data suggest Aderans is shooting for 2013 and Histogen saying 2013 Asia and 2015 US. My question is why? Is it a matter of funding or simply being extra careful to make sure everything is perfect. I would think if photos of what Histogen has produced are typical that they would be running to the finish line wide open instead of saying we hope to have a product in 5 years? If they have a product that was able to produce the results shown in thier photo why not give it to consumers let them sign away the rights regarding risk and let that serve as your trials. I realize that the FDA approval process will be slow but if the product is ready then why 5 years. I could understand one year maybe two but five. It makes me think that these copmanies are not as close as they claim. Also, if Histogen does prove succesful in Asia in 2013 will the treatment somehow sneak its way into the USA but simply be a non FDA approved treatment.